Consolidated Portfolio Review Corp »

Novo Nordisk A/S shares owned by Consolidated Portfolio Review Corp

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Consolidated Portfolio Review Corp from 13F filings

Historical chart of Consolidated Portfolio Review Corp investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Consolidated Portfolio Review Corp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Consolidated Portfolio Review Corp

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.9M 15k 128.40
2023-12-31 $1.5M 15k 103.45

More positions owned by Consolidated Portfolio Review Corp

Vanguard Bd Index Fds Intermed Term (BIV)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Growth Etf (VUG)
Vanguard World Health Car Etf (VHT)
Microsoft Corporation (MSFT)
Goldman Sachs Etf Tr Equal Weight Us (GSEW)
Vanguard Index Fds Value Etf (VTV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Apple (AAPL)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Vanguard World Consum Stp Etf (VDC)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Amazon (AMZN)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
NVIDIA Corporation (NVDA)

View all positions for Consolidated Portfolio Review Corp

Top funds holding Novo Nordisk A/S

Jennison Associates
FMR
Fisher Investments
Bank of America Corporation
Morgan Stanley
Fayez Sarofim & Co
Loomis, Sayles and
Folketrygdfondet
T. Rowe Price Associates
Polen Capital Management
BlackRock
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Jpmorgan Chase & Co
Royal Bank of Canada

View all funds holding Novo Nordisk A/S